A diabetes diagnosis isn’t the same for everyone. While each type of diabetes is characterized by high blood sugar, type 1, ...

The rise in type 2 diabetes cases globally presents opportunities for growth in the market for GLP-1 drugs like Ozempic and ...

Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, today announced ...

Study conducted by NCD Risk Factor Collaboration (NCD-RisC) and WHO. Findings part of first global analysis of trends in both ...

Ozempic (semaglutide) and Victoza (liraglutide) are prescription drugs used to treat type 2 diabetes and reduce the ... The following chart lists examples of mild side effects that can most ...

He said the "War on Sugar” campaign is a government initiative to reduce the intake of sugar among the people as a measure to tackle non-communicable diseases (NCDs) such as diabetes.

Performing computerized analysis to identify patients receiving target drugs that ... a source of comparison doses but were used to compare the efficiency and effectiveness of chart reviewers ...

CHICAGO (CBS) – A groundbreaking treatment for type 1 diabetes is showing promising ... insulin requirement and hopes to stop soon. "This medication has a great potential to be less toxic ...

The biggest surprise in the quarter came from weight-loss drug Zepbound and diabetes drug Mounjaro, which together came in nearly $900 million below estimates. Lilly’s success story “has been ...

GLP-1RAs may lead to rapid weight loss in type 1 diabetes, complicating insulin management. Use of these drugs in type 1 diabetes has grown driven by the need to address obesity, heart, and kidney ...

Alternatively, they may adjust your medications to help prevent your blood pressure from dropping too much. Also, insulin and other diabetes medications that mimic insulin (including sulfonylureas) ...

Participants received their type 2 diabetes diagnosis within the previous 10 years and were being treated with diet or medications but were not using insulin. Researchers had participants ...